Xuebijing injection alleviates septic acute kidney injury by modulating inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress
This study indicates that XBJ injection is a promising drug for the treatment of septic AKI.
Authors
- Shuchun Tao
- Shuqiu Chen (ORCID: https://orcid.org/0000-0001-9128-8633)
- Guangyuan Zhang (ORCID: https://orcid.org/0009-0009-1728-770X)
- Weipu Mao (ORCID: https://orcid.org/0000-0002-3878-5224)
- Nieke Zhang
- Ming Chen (ORCID: https://orcid.org/0000-0002-3572-6886)
- Lei Zhang (ORCID: https://orcid.org/0009-0008-9783-092X)
- Si Sun
- Yue Gao (ORCID: https://orcid.org/0009-0003-9617-3968)
- Guiya Jiang
- Xun Lu (ORCID: https://orcid.org/0000-0002-4992-0241)
Institutions
- Southeast University (BD)
- Zhongda Hospital Southeast University (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Southeast University (CN)
Publication Details
- Journal
- Renal Failure
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1080/0886022x.2025.2483986
- Citations
- 3
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.73
Funders
- National Natural Science Foundation of China